Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models
出版年份 2018 全文链接
标题
Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models
作者
关键词
-
出版物
CELL DEATH AND DIFFERENTIATION
Volume 25, Issue 3, Pages 616-633
出版商
Springer Nature
发表日期
2018-01-05
DOI
10.1038/s41418-017-0011-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies
- (2017) M. Del Rio et al. EUROPEAN JOURNAL OF CANCER
- Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors
- (2017) Moritz Schütte et al. Nature Communications
- Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer
- (2017) Claudio Isella et al. Nature Communications
- Methylation of WNT target genes AXIN2 and DKK1 as robust biomarkers for recurrence prediction in stage II colon cancer
- (2017) R Kandimalla et al. Oncogenesis
- A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis
- (2016) Masayuki Fujii et al. Cell Stem Cell
- Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry
- (2016) Anne Trinh et al. CLINICAL CANCER RESEARCH
- TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype
- (2016) Evelyn Fessler et al. EMBO Molecular Medicine
- A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype
- (2016) E Fessler et al. ONCOGENE
- Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes
- (2016) Nan Song et al. JAMA Oncology
- Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
- (2015) Marc van de Wetering et al. CELL
- Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2015) Jin Li et al. LANCET ONCOLOGY
- Stromal gene expression defines poor-prognosis subtypes in colorectal cancer
- (2015) Alexandre Calon et al. NATURE GENETICS
- Stromal contribution to the colorectal cancer transcriptome
- (2015) Claudio Isella et al. NATURE GENETICS
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases
- (2015) Fleur Weeber et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets
- (2015) Enzo Medico et al. Nature Communications
- Cancer Cell Lines for Drug Discovery and Development
- (2014) J. L. Wilding et al. CANCER RESEARCH
- Colorectal Cancer Cell Lines Are Representative Models of the Main Molecular Subtypes of Primary Cancer
- (2014) D. Mouradov et al. CANCER RESEARCH
- Predicting the functional consequences of cancer-associated amino acid substitutions
- (2013) Hashem A. Shihab et al. BIOINFORMATICS
- Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition
- (2013) Paul Roepman et al. INTERNATIONAL JOURNAL OF CANCER
- Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
- (2013) Eva Budinska et al. JOURNAL OF PATHOLOGY
- Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions
- (2013) Felipe De Sousa E Melo et al. NATURE MEDICINE
- IntOGen-mutations identifies cancer drivers across tumor types
- (2013) Abel Gonzalez-Perez et al. NATURE METHODS
- Phenotypic and Transcriptional Fidelity of Patient-Derived Colon Cancer Xenografts in Immune-Deficient Mice
- (2013) Jeffrey Chou et al. PLoS One
- Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
- (2013) Laetitia Marisa et al. PLOS MEDICINE
- Epigenetic and genetic features of 24 colon cancer cell lines
- (2013) D Ahmed et al. Oncogenesis
- Villin Expression Is Frequently Lost in Poorly Differentiated Colon Cancer
- (2012) Diego Arango et al. AMERICAN JOURNAL OF PATHOLOGY
- Colon cancer molecular subtypes identified by expression profiling and associatedto stroma, mucinous type and different clinical behavior
- (2012) Beatriz Perez Villamil et al. BMC CANCER
- Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines
- (2012) Andreas Schlicker et al. BMC Medical Genomics
- Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis Initiation
- (2012) Alexandre Calon et al. CANCER CELL
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) Axel Grothey et al. LANCET
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Methylation of Cancer-Stem-Cell-Associated Wnt Target Genes Predicts Poor Prognosis in Colorectal Cancer Patients
- (2011) Felipe de Sousa E Melo et al. Cell Stem Cell
- Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
- (2011) Toshiro Sato et al. GASTROENTEROLOGY
- Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
- (2011) Yoko S DeRose et al. NATURE MEDICINE
- A Molecularly Annotated Platform of Patient-Derived Xenografts ("Xenopatients") Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
- (2011) A. Bertotti et al. Cancer Discovery
- Frozen robust multiarray analysis (fRMA)
- (2010) M. N. McCall et al. BIOSTATISTICS
- KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- Two Multiplex Assays That Simultaneously Identify 22 Possible Mutation Sites in the KRAS, BRAF, NRAS and PIK3CA Genes
- (2010) Irene Lurkin et al. PLoS One
- lumi: a pipeline for processing Illumina microarray
- (2008) P. Du et al. BIOINFORMATICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now